REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Conditions
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
- Axial Spondyloarthritis (AxSpA)
Interventions
- DRUG: JAKi dose reduction strategy
- DRUG: JAKi disease activity guided continuation of same dose strategy
Sponsor
Sint Maartenskliniek
Collaborators